Navigation Links
Patton Boggs Wins Landmark Insurance Case for Client
Date:2/26/2009

WASHINGTON, Feb. 26 /PRNewswire/ -- A recent decision issued by the U.S. District Court for the Southern District of New York could have significant implications for the insurance industry. The February 13 ruling from U.S. District Judge Richard J. Holwell clarifies a decision the court entered two months earlier establishing that Texas law requires issuers of directors & officers (D&O) liability policies to advance defense costs incurred in connection with covered and non-covered causes of action interposed in the same lawsuit.

In an opinion dated December 19, 2008, Judge Holwell ruled that a lawsuit against Uncle Julio's restaurant chain contained a covered cause of action ("breach of fiduciary duty") and an excluded cause of action ("breach of contract"). Judge Holwell further ruled that Travelers Insurance, the issuer of Uncle Julio's D&O policy, was not only required to advance defense costs allocable to the covered cause of action, but also any defense costs that might be allocable to the non-covered cause of action. The insurer then moved for clarification of the bases for this latter aspect of the December 2008 ruling.

Judge Holwell clarified his earlier ruling in the February 13 opinion and agreed with the argument put forth by Patton Boggs senior litigation partner, John W. Schryber that the policy required advances of defense costs incurred in connection with a "Claim," and "the policy's definition of Claim ... clearly contemplates the equivalence of the word 'lawsuit' ... ." "Under this interpretation," Judge Holwell held, the insurer's duty to advance extends to "the entire lawsuit."

By operation of these rulings, the insured stands to recover in excess of $1 million for the insurer's breach of its duty to advance defense costs.

Mr. Schryber, who argued the case, stated: "For years, D&O insurers have sought to impose 'allocation' conditions on policyholders who purchased D&O policies without any allocation clause. This ruling should bring an end to the insurers' practice of seeking allocation under a policy that does not contain an allocation clause."

Patton Boggs LLP

Based in Washington DC, Patton Boggs is a national leader in public policy, litigation, and business law, and is well known for its deep bipartisan roots in the national political arena. The firm's core practice areas are Public Policy and Regulatory, Litigation, Business, and Intellectual Property. With offices in Northern Virginia, New Jersey, New York, Dallas, Denver, Anchorage, and internationally in Doha, Qatar and Abu Dhabi, UAE, our more than 600 lawyers and professionals provide comprehensive, practical, and cost-effective legal counsel to clients around the globe. For more information, visit us at www.pattonboggs.com. To receive press releases from Patton Boggs, please contact Rebecca Carr at rcarr@pattonboggs.com.


'/>"/>
SOURCE Patton Boggs LLP
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Landmark Policy Report: Many Cancers Could Be Prevented Across the Globe
2. Landmark Report: Many Cancers Could be Prevented
3. Update on Landmark Study on Single-Payer as Economic Stimulus
4. Alliance for a Healthier Generation Expands Efforts to Combat Childhood Obesity with Launch of Landmark Healthcare Initiative
5. Landmark Trial Provides Vital Information for Cardiac Disease Treatment
6. Landmark Rh Immune Globulin Celebrates 40 Years of Saving Babies Lives
7. Landmark textbook on strokes in children and young adults updated in second edition
8. Hope for Lung Cancer Research Dollars in California: The Bonnie J. Addario Lung Cancer Foundation (BJALCF) Applauds Landmark Legislation to Push through Funding for Lung Cancer Research in California
9. Coalition for Pulmonary Fibrosis Celebrates Landmark Year for Awareness, Advocacy, Research
10. First Patient from CyberKnife Center of Palm Beach Enrolled in Worldwide Landmark Study of Operable Lung Cancer Patients
11. Exjade(R) Benefits Chronically Transfused Patients by Significantly Reducing Toxic Iron That Can Damage Key Organs, According to Landmark Trial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... NC (PRWEB) , ... June 26, 2016 , ... Brent Kasmer, a legally blind and ... to be personalized through a fitness app. The fitness app plans to fix the two ... currently only offer a one size fits all type program , They don’t ...
(Date:6/25/2016)... ... June 25, 2016 , ... "With 30 hand-drawn hand ... project," said Christina Austin - CEO of Pixel Film Studios. , ProHand Cartoon’s ... within Final Cut Pro X . Simply select a ProHand generator and drag ...
(Date:6/25/2016)... Canada (PRWEB) , ... June 25, 2016 , ... Conventional ... pursuit of success. In terms of the latter, setting the bar too high can ... risk more than just slow progress toward their goal. , Research from ...
(Date:6/24/2016)... ... 24, 2016 , ... The Pulmonary Hypertension Association (PHA) learned ... receive two significant new grants to support its work to advance research and ... by recognizing patients, medical professionals and scientists for their work in fighting pulmonary ...
(Date:6/24/2016)... ... June 24, 2016 , ... People across the U.S. are ... Code Talker Award, an essay contest in which patients and their families pay tribute ... presented at the 2016 National Society of Genetic Counselors (NSGC) Annual Education Conference (AEC) ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... , June 23, 2016 Research and ... Global Market - Forecast to 2022" report to their ... treatment method for the patients with kidney failure, it replaces ... fluid from the patient,s blood and thus the treatment helps ... and chloride in balance. Increasing number of ...
(Date:6/23/2016)... DUBLIN , June 23, 2016 ... the "Pharmaceutical Excipients Market by Type (Organic Chemical ... Preservative), Formulation (Oral, Topical, Coating, Parenteral) - Global Forecast ... The global pharmaceutical excipients ... 2021 at a CAGR of 6.1% in the forecast ...
(Date:6/23/2016)... June 23, 2016 Roche (SIX: RO, ROG; ... for its Elecsys BRAHMS PCT (procalcitonin) assay as a ... septic shock. With this clearance, Roche is the first ... integrated solution for sepsis risk assessment and management. ... infection and PCT levels in blood can aid clinicians ...
Breaking Medicine Technology: